Matches in DBpedia 2016-04 for { <http://wikidata.dbpedia.org/resource/Q6995920> ?p ?o }
Showing triples 1 to 45 of
45
with 100 triples per page.
- Q6995920 subject Q52309.
- Q6995920 subject Q52359.
- Q6995920 subject Q7071513.
- Q6995920 subject Q7116685.
- Q6995920 subject Q7335370.
- Q6995920 subject Q8248726.
- Q6995920 subject Q8636858.
- Q6995920 subject Q8919936.
- Q6995920 subject Q8965786.
- Q6995920 abstract "Neratinib (HKI-272) is a tyrosine kinase inhibitor under investigation for the treatment of breast cancer and other solid tumours.It is in development for the treatment of early- and late-stage HER2-positive breast cancer.Like lapatinib and afatinib, it is a dual inhibitor of the human epidermal growth factor receptor 2 (Her2) and epidermal growth factor receptor (EGFR) kinases.".
- Q6995920 atcPrefix "none".
- Q6995920 casNumber "698387-09-6".
- Q6995920 fdaUniiCode "JJH94R3PWB".
- Q6995920 iupacName "(2E)-N-[4-[[3-chloro-4-[(pyridin-2-yl)methoxy]phenyl]amino]-3-cyano-7-ethoxyquinolin-6-yl]-4-(dimethylamino)but-2-enamide".
- Q6995920 pubchem "9915743".
- Q6995920 thumbnail Neratinib_skeletal.svg?width=300.
- Q6995920 wikiPageWikiLink Q128581.
- Q6995920 wikiPageWikiLink Q14865565.
- Q6995920 wikiPageWikiLink Q14877486.
- Q6995920 wikiPageWikiLink Q16242548.
- Q6995920 wikiPageWikiLink Q420323.
- Q6995920 wikiPageWikiLink Q4688818.
- Q6995920 wikiPageWikiLink Q52309.
- Q6995920 wikiPageWikiLink Q52359.
- Q6995920 wikiPageWikiLink Q7071513.
- Q6995920 wikiPageWikiLink Q7116685.
- Q6995920 wikiPageWikiLink Q7335370.
- Q6995920 wikiPageWikiLink Q8248726.
- Q6995920 wikiPageWikiLink Q8636858.
- Q6995920 wikiPageWikiLink Q8919936.
- Q6995920 wikiPageWikiLink Q8965786.
- Q6995920 wikiPageWikiLink Q906415.
- Q6995920 atcPrefix "none".
- Q6995920 casNumber "698387".
- Q6995920 iupacName "-N-[4-[[3-chloro-4-[methoxy]phenyl]amino]-3-cyano-7-ethoxyquinolin-6-yl]-4-but-2-enamide".
- Q6995920 pubchem "9915743".
- Q6995920 unii "JJH94R3PWB".
- Q6995920 type ChemicalSubstance.
- Q6995920 type Drug.
- Q6995920 type ChemicalObject.
- Q6995920 type Thing.
- Q6995920 type Q8386.
- Q6995920 comment "Neratinib (HKI-272) is a tyrosine kinase inhibitor under investigation for the treatment of breast cancer and other solid tumours.It is in development for the treatment of early- and late-stage HER2-positive breast cancer.Like lapatinib and afatinib, it is a dual inhibitor of the human epidermal growth factor receptor 2 (Her2) and epidermal growth factor receptor (EGFR) kinases.".
- Q6995920 label "Neratinib".
- Q6995920 depiction Neratinib_skeletal.svg.